Sign up to save your podcasts
Or
Share E138: Dapirolizumab for SLE (PHOENYCS-GO)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E138: Dapirolizumab for SLE (PHOENYCS-GO)
A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The study itself was a qualified success and the podcast got a bit more rant-y than it should have been, but hopefully you get a kick out of it.
Paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00691-4/fulltext
View all episodes
By Michael Putman
4.9
114114 ratings
A new therapy for SLE! This one is a CD40-CD40L blocker, which has some nice new-things to inhibit. The study itself was a qualified success and the podcast got a bit more rant-y than it should have been, but hopefully you get a kick out of it.
Paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00691-4/fulltext
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
506 Listeners
Mayo Clinic Talks
299 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
ACR on Air
68 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
The Curious Clinicians
373 Listeners
Rheumatology For The Royal College
182 Listeners
Febrile
188 Listeners
ACR Journals On Air
17 Listeners
Talking Rheumatology Spotlight
6 Listeners